297 lead form fill jobs found

Refine Search
Current Search
Biotech lead form fill
Refine by Categories
Refine by Job Type
Refine by Salary Range
Refine by City
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (KS)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (AR)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (NE)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Senior Program Manager, CMS
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Medical Science Liaison - Central
Dendreon Remote (United States)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Senior Director/Vice President, Site Operations
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Customer Order Specialist
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Key Account Manager - Seattle
Dendreon Seattle, WA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Facilities Mechanic
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Key Account Manager - San Francisco
Dendreon San Francisco, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Sr. Clinical Research Associate
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Senior Director, Marketing
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Manager, Sourcing and Procurement
Dendreon Seal Beach, CA
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Key Account Manager - Upstate New York
Dendreon Remote (New York, NY)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (MN)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (WI)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (MI)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (IA)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.